X0306 4 2020-02-28 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001724567 Schultz Kare C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET PETACH TIKVA L3 4951033 ISRAEL 1 1 0 0 President and CEO Restricted Share Units 2020-02-28 4 A 0 260190 0.00 A Ordinary Shares 260190 260190 D Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on February 28, 2020 with 65,047 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 65,049 vesting on February 28, 2024. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. /s/ Dov Bergwerk as attorney-in-fact for Kare Schultz 2020-03-03